70/100B203.570
USD
-5.91
(-2.82%)
Market Open
Last updated: · Delayed 15 min
Illumina price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Illumina's P/S ratio is 6.78: its market cap of 30.78B USD over revenue of 4.54B USD in the last twelve months.
- Today
- 6.78
- Average, 5 years
- 6.05
- Low, 5 years
- 2.56
- High, 5 years
- 15.09
P/S ratio = market cap ÷ revenue (last 12 months) = 30.78B ÷ 4.54B = 6.78
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 6.78 | 30.78B | 4.54B | |
| FY2025 | 28 Dec 2025 | 4.81 | 20.84B | 4.34B |
| FY2024 | 29 Dec 2024 | 4.86 | 21.24B | 4.37B |
| FY2023 | 31 Dec 2023 | 4.75 | 21.38B | 4.50B |
| FY2022 | 1 Jan 2023 | 6.73 | 30.85B | 4.58B |
| FY2021 | 2 Jan 2022 | 12.27 | 55.52B | 4.53B |
| FY2020 | 3 Jan 2021 | 16.22 | 52.54B | 3.24B |
| FY2019 | 29 Dec 2019 | 13.23 | 46.88B | 3.54B |
| FY2018 | 31 Dec 2018 | 12.86 | 42.85B | 3.33B |
| FY2017 | 31 Dec 2017 | 11.27 | 31.00B | 2.75B |
| FY2016 | 31 Dec 2016 | 7.63 | 18.29B | 2.40B |
| FY2015 | 31 Dec 2015 | 12.19 | 27.05B | 2.22B |
| FY2014 | 31 Dec 2014 | 13.06 | 24.32B | 1.86B |
| FY2013 | 31 Dec 2013 | 9.46 | 13.44B | 1.42B |
| FY2012 | 31 Dec 2012 | 5.79 | 6.64B | 1.15B |
| FY2011 | 31 Dec 2011 | 3.46 | 3.66B | 1.06B |
| FY2010 | 31 Dec 2010 | 8.43 | 7.61B | 902.74M |
| FY2009 | 31 Dec 2009 | 5.51 | 3.67B | 666.32M |
| FY2008 | 31 Dec 2008 | 5.16 | 2.96B | 573.23M |
| FY2007 | 31 Dec 2007 | 8.50 | 3.12B | 366.80M |
| FY2006 | 31 Dec 2006 | 9.21 | 1.70B | 184.59M |
| FY2005 | 31 Dec 2005 | 7.48 | 550.01M | 73.50M |
| FY2004 | 31 Dec 2004 | 6.53 | 330.49M | 50.58M |
| FY2003 | 31 Dec 2003 | 7.81 | 219.01M | 28.04M |
| FY2002 | 31 Dec 2002 | 10.09 | 101.32M | 10.04M |
| FY2001 | 31 Dec 2001 | 136.65 | 339.72M | 2.49M |
| FY2000 | 31 Dec 2000 | 331.89 | 434.49M | 1.31M |
| FY1999 | 31 Dec 1999 | 113.23 | 53.67M | 474.03K |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 27 Sept 2026 | 9.05 | 41.06B | 4.54B |
| Q2 FY2026 | 28 Jun 2026 | 6.09 | 27.35B | 4.49B |
| Q1 FY2026 | 29 Mar 2026 | 4.21 | 18.48B | 4.39B |
| Q4 FY2025 | 28 Dec 2025 | 4.74 | 20.58B | 4.34B |
| Q3 FY2025 | 28 Sept 2025 | 3.28 | 14.06B | 4.29B |
| Q2 FY2025 | 29 Jun 2025 | 3.50 | 14.98B | 4.28B |
| Q1 FY2025 | 30 Mar 2025 | 2.91 | 12.62B | 4.34B |
| Q4 FY2024 | 29 Dec 2024 | 4.86 | 21.24B | 4.37B |
| Q3 FY2024 | 29 Sept 2024 | 4.72 | 20.74B | 4.39B |
| Q2 FY2024 | 30 Jun 2024 | 3.79 | 16.77B | 4.43B |
| Q1 FY2024 | 31 Mar 2024 | 4.56 | 20.51B | 4.49B |
| Q4 FY2023 | 31 Dec 2023 | 4.78 | 21.52B | 4.50B |
| Q3 FY2023 | 1 Oct 2023 | 4.69 | 20.95B | 4.47B |
| Q2 FY2023 | 2 Jul 2023 | 6.48 | 28.89B | 4.46B |
| Q1 FY2023 | 2 Apr 2023 | 7.94 | 35.32B | 4.45B |
| Q4 FY2022 | 31 Dec 2022 | 6.77 | 31.05B | 4.58B |
| Q3 FY2022 | 2 Oct 2022 | 6.08 | 28.57B | 4.70B |
| Q2 FY2022 | 3 Jul 2022 | 6.21 | 29.15B | 4.69B |
| Q1 FY2022 | 3 Apr 2022 | 11.98 | 55.77B | 4.66B |
| Q4 FY2021 | 31 Dec 2021 | 12.83 | 58.05B | 4.53B |
| Q3 FY2021 | 3 Oct 2021 | 13.11 | 56.12B | 4.28B |
| Q2 FY2021 | 4 Jul 2021 | 16.98 | 67.36B | 3.97B |
| Q1 FY2021 | 4 Apr 2021 | 15.71 | 54.56B | 3.47B |
| Q4 FY2020 | 31 Dec 2020 | 16.21 | 52.50B | 3.24B |
| Q3 FY2020 | 27 Sept 2020 | 13.39 | 43.34B | 3.24B |
| Q2 FY2020 | 28 Jun 2020 | 15.45 | 51.76B | 3.35B |
| Q1 FY2020 | 29 Mar 2020 | 11.10 | 39.46B | 3.56B |
| Q4 FY2019 | 31 Dec 2019 | 13.38 | 47.39B | 3.54B |
| Q3 FY2019 | 29 Sept 2019 | 12.57 | 43.46B | 3.46B |
| Q2 FY2019 | 30 Jun 2019 | 15.56 | 52.95B | 3.40B |
| Q1 FY2019 | 31 Mar 2019 | 13.33 | 45.26B | 3.40B |
| Q4 FY2018 | 31 Dec 2018 | 12.86 | 42.85B | 3.33B |
| Q3 FY2018 | 30 Sept 2018 | 16.15 | 52.36B | 3.24B |
| Q2 FY2018 | 1 Jul 2018 | 12.84 | 39.86B | 3.10B |
| Q1 FY2018 | 1 Apr 2018 | 11.19 | 32.85B | 2.94B |
| Q4 FY2017 | 31 Dec 2017 | 11.27 | 31.00B | 2.75B |
| Q3 FY2017 | 1 Oct 2017 | 11.06 | 28.69B | 2.59B |
| Q2 FY2017 | 2 Jul 2017 | 9.94 | 24.71B | 2.49B |
| Q1 FY2017 | 2 Apr 2017 | 9.99 | 24.23B | 2.42B |
| Q4 FY2016 | 31 Dec 2016 | 7.62 | 18.27B | 2.40B |
| Q3 FY2016 | 2 Oct 2016 | 10.98 | 26.03B | 2.37B |
| Q2 FY2016 | 3 Jul 2016 | 8.69 | 20.11B | 2.31B |
| Q1 FY2016 | 3 Apr 2016 | 10.63 | 23.94B | 2.25B |
| Q4 FY2015 | 31 Dec 2015 | 12.27 | 27.23B | 2.22B |
| Q3 FY2015 | 27 Sept 2015 | 11.05 | 23.66B | 2.14B |
| Q2 FY2015 | 28 Jun 2015 | 14.48 | 29.99B | 2.07B |
| Q1 FY2015 | 29 Mar 2015 | 13.25 | 26.22B | 1.98B |
| Q4 FY2014 | 31 Dec 2014 | 13.72 | 25.53B | 1.86B |
| Q3 FY2014 | 28 Sept 2014 | 13.05 | 22.66B | 1.74B |
| Q2 FY2014 | 29 Jun 2014 | 14.05 | 22.66B | 1.61B |
| Q1 FY2014 | 30 Mar 2014 | 12.25 | 18.51B | 1.51B |
| Q4 FY2013 | 31 Dec 2013 | 9.58 | 13.62B | 1.42B |
| Q3 FY2013 | 29 Sept 2013 | 7.34 | 9.86B | 1.34B |
| Q2 FY2013 | 30 Jun 2013 | 7.25 | 9.22B | 1.27B |
| Q1 FY2013 | 31 Mar 2013 | 5.41 | 6.52B | 1.21B |
| Q4 FY2012 | 31 Dec 2012 | 5.80 | 6.66B | 1.15B |
| Q3 FY2012 | 30 Sept 2012 | 5.38 | 5.86B | 1.09B |
| Q2 FY2012 | 1 Jul 2012 | 4.74 | 4.93B | 1.04B |
| Q1 FY2012 | 1 Apr 2012 | 5.85 | 6.12B | 1.05B |
| Q4 FY2011 | 31 Dec 2011 | 3.41 | 3.60B | 1.06B |
| Q3 FY2011 | 2 Oct 2011 | 4.25 | 4.53B | 1.07B |
| Q2 FY2011 | 3 Jul 2011 | 8.53 | 9.12B | 1.07B |
| Q1 FY2011 | 3 Apr 2011 | 8.71 | 8.65B | 993.13M |
| Q4 FY2010 | 31 Dec 2010 | 10.31 | 9.31B | 902.74M |
| Q3 FY2010 | 3 Oct 2010 | 7.34 | 6.03B | 822.01M |
| Q2 FY2010 | 4 Jul 2010 | 6.94 | 5.16B | 743.06M |
| Q1 FY2010 | 4 Apr 2010 | 6.65 | 4.60B | 692.70M |
| Q4 FY2009 | 31 Dec 2009 | 6.09 | 4.06B | 666.32M |
| Q3 FY2009 | 27 Sept 2009 | 7.73 | 5.00B | 646.69M |
| Q2 FY2009 | 28 Jun 2009 | 7.28 | 4.65B | 638.59M |
| Q1 FY2009 | 29 Mar 2009 | 7.07 | 4.36B | 617.12M |
| Q4 FY2008 | 31 Dec 2008 | 5.80 | 3.32B | 573.23M |
| Q3 FY2008 | 28 Sept 2008 | 8.95 | 4.70B | 524.90M |
| Q2 FY2008 | 29 Jun 2008 | 10.18 | 4.81B | 472.15M |
| Q1 FY2008 | 30 Mar 2008 | 9.89 | 4.12B | 416.51M |
| Q4 FY2007 | 31 Dec 2007 | 8.64 | 3.17B | 366.80M |
| Q3 FY2007 | 30 Sept 2007 | 8.70 | 2.74B | 314.63M |
| Q2 FY2007 | 1 Jul 2007 | 8.00 | 2.16B | 270.59M |
| Q1 FY2007 | 1 Apr 2007 | 6.67 | 1.52B | 227.63M |
| Q4 FY2006 | 31 Dec 2006 | 10.47 | 1.93B | 184.59M |
| Q3 FY2006 | 1 Oct 2006 | 10.07 | 1.48B | 147.16M |
| Q2 FY2006 | 2 Jul 2006 | 11.39 | 1.29B | 113.21M |
| Q1 FY2006 | 2 Apr 2006 | 10.77 | 942.31M | 87.46M |
| Q4 FY2005 | 31 Dec 2005 | 8.33 | 612.39M | 73.50M |
| Q3 FY2005 | 2 Oct 2005 | 8.00 | 522.01M | 65.27M |
| Q2 FY2005 | 3 Jul 2005 | 8.11 | 480.64M | 59.27M |
| Q1 FY2005 | 3 Apr 2005 | 5.43 | 298.34M | 54.93M |
| Q4 FY2004 | 31 Dec 2004 | 7.05 | 356.46M | 50.58M |
| Q3 FY2004 | 3 Oct 2004 | 5.16 | 239.98M | 46.54M |
| Q2 FY2004 | 27 Jun 2004 | 5.10 | 210.46M | 41.28M |
| Q1 FY2004 | 28 Mar 2004 | 6.52 | 225.24M | 34.56M |
| Q4 FY2003 | 31 Dec 2003 | 7.89 | 221.24M | 28.04M |
| Q3 FY2003 | 28 Sept 2003 | 7.90 | 167.33M | 21.18M |
| Q2 FY2003 | 29 Jun 2003 | 5.48 | 87.15M | 15.92M |
| Q1 FY2003 | 30 Mar 2003 | 5.33 | 69.48M | 13.05M |
| Q4 FY2002 | 31 Dec 2002 | 10.23 | 102.66M | 10.04M |
| Q3 FY2002 | 29 Sept 2002 | 15.01 | 103.78M | 6.92M |
| Q2 FY2002 | 30 Jun 2002 | 40.16 | 185.62M | 4.62M |
| Q1 FY2002 | 31 Mar 2002 | 69.47 | 221.71M | 3.19M |
| Q4 FY2001 | 31 Dec 2001 | 138.61 | 344.59M | 2.49M |
| Q3 FY2001 | 30 Sept 2001 | 82.91 | 183.18M | 2.21M |
| Q2 FY2001 | 30 Jun 2001 | 155.57 | 339.26M | 2.18M |
| Q1 FY2001 | 31 Mar 2001 | 112.02 | 200.47M | 1.79M |
| Q4 FY2000 | 31 Dec 2000 | 348.69 | 456.47M | 1.31M |
| Q3 FY2000 | 30 Sept 2000 | — | 1.16B | — |
| Q2 FY2000 | 30 Jun 2000 | — | 814.55M | — |
| Q1 FY2000 | 31 Mar 2000 | — | 82.78M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Illumina's P/S ratio
Source: Financial Modeling Prep